Caenorhabditis Intervention Testing Program: the putative mTOR inhibitors Cinnarizine and Meclizine do not extend lifespan in C. elegans

Erik Johnson, Christine A. Sedore, Anna L. Coleman-Hulbert, Brian D. Onken, Vijaya Madhuri Achanta, Yuhua Song, Gino Cortopassi, Gordon J. Lithgow, Monica Driscoll, Patrick C. Phillips · 2026

Read Caenorhabditis Intervention Testing Program: the putative mTOR inhibitors Cinnarizine and Meclizine do not extend lifespan in C. elegans by Erik Johnson, Christine A. Sedore, Anna L. Coleman-Hulbert, Brian D. Onken, Vijaya Madhuri Achanta, Yuhua Song, Gino Cortopassi, Gordon J. Lithgow, Monica Driscoll, Patrick C. Phillips (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13617457.txt.

Description

Erik Johnson and co-authors test two common drugs for lifespan gains in a tiny worm, in work from 2026. Blocking a master growth regulator extends life in many species, making it a top aging target. Two everyday drugs were thought to block that regulator as well.

The trial program used standard protocols across labs for a fair test. At low doses, neither drug changed worm lifespan at all. At higher doses, both drugs proved toxic and cut lifespan short. The clear negative result saves effort that might chase these drugs as aging therapies. It also shows the value of shared testing pipelines that publish failures, not just wins.

Catalog record

CREATORErik Johnson, Christine A. Sedore, Anna L. Coleman-Hulbert, Brian D. Onken, Vijaya Madhuri Achanta, Yuhua Song, Gino Cortopassi, Gordon J. Lithgow, Monica Driscoll, Patrick C. Phillips
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE10 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13617457

Browse the full library · About the Tower of Babel